These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
661 related articles for article (PubMed ID: 15494777)
1. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Beck-da-Silva L; de Bold A; Fraser M; Williams K; Haddad H Can J Cardiol; 2004 Oct; 20(12):1245-8. PubMed ID: 15494777 [TBL] [Abstract][Full Text] [Related]
2. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion. Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659 [TBL] [Abstract][Full Text] [Related]
3. Decreased plasma brain natriuretic peptide levels after a successful maze procedure. Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326 [TBL] [Abstract][Full Text] [Related]
4. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation. Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Goudis CA; Maliaraki NE; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE Am J Cardiol; 2010 Jan; 105(1):90-4. PubMed ID: 20102897 [TBL] [Abstract][Full Text] [Related]
5. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Wozakowska-Kapłon B; Opolski G Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030 [TBL] [Abstract][Full Text] [Related]
6. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function. Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126 [TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation. Wozakowska-Kapłon B; Opolski G; Janion M Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556 [TBL] [Abstract][Full Text] [Related]
8. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Wozakowska-Kapłon B Am J Cardiol; 2004 Jun; 93(12):1555-8. PubMed ID: 15194036 [TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Vinch CS; Rashkin J; Logsetty G; Tighe DA; Hill JC; Meyer TE; Rosenthal LS; Aurigemma GP Cardiology; 2004; 102(4):188-93. PubMed ID: 15452391 [TBL] [Abstract][Full Text] [Related]
10. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231 [TBL] [Abstract][Full Text] [Related]
11. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation. Buob A; Jung J; Siaplaouras S; Neuberger HR; Mewis C Pacing Clin Electrophysiol; 2006 Jun; 29(6):559-63. PubMed ID: 16784419 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion. Lellouche N; Berthier R; Mekontso-Dessap A; Braconnier F; Monin JL; Duval AM; Dubois-Randé JL; Guéret P; Garot J Am J Cardiol; 2005 Jun; 95(11):1380-2. PubMed ID: 15904651 [TBL] [Abstract][Full Text] [Related]
13. Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation. Boodhoo LE; Mitchell AR; O'Connor J; Sulke N Int J Cardiol; 2005 Aug; 103(1):67-72. PubMed ID: 16061126 [TBL] [Abstract][Full Text] [Related]
14. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation. Shang YP; Lai L; Chen J; Zhang F; Wang X J Heart Valve Dis; 2005 Jul; 14(4):453-9. PubMed ID: 16116870 [TBL] [Abstract][Full Text] [Related]
15. Sinus rhythm restoration after atrial fibrillation: the clinical value of N-terminal pro-BNP measurements. Danicek V; Theodorovich N; Bar-Chaim S; Miller A; Vered Z; Koren-Morag N; Uriel N; Czuriga I; Shopen A; Brantriss N; Kaluski E Pacing Clin Electrophysiol; 2008 Aug; 31(8):955-60. PubMed ID: 18684250 [TBL] [Abstract][Full Text] [Related]
16. Exercise-induced natriuretic peptide secretion predicts cardioversion outcome in patients with persistent atrial fibrillation: discordant ANP and B-type natriuretic peptide response to exercise testing. Wozakowska-Kaplon B; Opolski G Pacing Clin Electrophysiol; 2010 Oct; 33(10):1203-9. PubMed ID: 20487352 [TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance. Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436 [TBL] [Abstract][Full Text] [Related]
18. Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion. Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Arnesen H; Smith P Int J Cardiol; 2009 Jan; 131(2):234-9. PubMed ID: 18201783 [TBL] [Abstract][Full Text] [Related]
20. Time course for recovery of atrial mechanical and endocrine function post DC cardioversion for persistent atrial fibrillation. Thomas MD; Kalra PR; Jones A; Struthers AD; More RS Int J Cardiol; 2005 Jul; 102(3):487-91. PubMed ID: 16004895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]